KPV
Compoundable (Rx)Anti-Inflammatory Peptides · Gut Health
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH).
What is KPV?
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH). It possesses potent anti-inflammatory properties, particularly in the gastrointestinal tract, making it one of the most popular peptides for gut health and inflammatory conditions.
Also known as: Lysine-Proline-Valine, Alpha-MSH fragment
How Does KPV Work?
Enters cells and travels to the nucleus where it inhibits NF-κB inflammatory signaling. Reduces production of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Has direct antimicrobial effects. Crosses the blood-brain barrier and reduces neuroinflammation.
What is KPV Used For?
- Gut inflammation
- IBD/IBS support
- Anti-inflammatory
- Skin inflammation
Potential Side Effects
- Generally well-tolerated
- Mild GI discomfort (oral)
- Injection site irritation
Contraindications
- Pregnancy
- Children
- Active infection (may suppress needed inflammation)
FDA Legal Status
United States — FDA
Compoundable (Rx)Category 1 (restored 2026)
Related Peptides
BPC-157
Compoundable (Rx)Tissue Repair Peptides
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective protein found in human gastric j...
LL-37
Research OnlyAntimicrobial Peptides
LL-37 is the only human cathelicidin antimicrobial peptide, playing a key role in innate immune defense. It has broad-sp...
Frequently Asked Questions
Is KPV good for gut health?
Can KPV be taken orally?
Quick Facts
- Legal Status (USA)
- Compoundable (Rx)
- FDA Category
- Category 1 (restored 2026)
- Evidence Rating
- CPreliminary Evidence (Mostly Preclinical)
- Class / Subclass
- Anti-Inflammatory Peptides / Gut Health
- Administration
- oral, subcutaneous, topical
- Typical Dosage
- 200-500mcg 1-2x daily (oral/injectable)
- Half-Life
- ~2-3 hours
- Year Discovered
- 2000
Sources
Last updated: 2026-04-01
Sources & references
Primary sources used for the dosing, mechanism, side-effect, and regulatory claims on this page. Verify time-sensitive information (regulatory status, prescribing details) on the source before relying on it for medical decisions. See our disclaimer.
- PubMed PMID 16181638 — peer-reviewed primary literature on KPV.
- FDA Federal Register — official notice record for FDA regulatory actions and Category 1 / 503A bulk-substance updates.